Elevated white blood cell counts also appear to correlate with shorter overall survival in patients receiving standard induction chemotherapy plus cytarabine for acute myeloid leukemia. High serum ...
CLL-related immune dysfunction, along with therapy-associated immunosuppression, contributes to impaired tumor surveillance.
Hosted on MSN
What Is the Prognosis of Multiple Myeloma?
Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell in your bone marrow. Treatment for multiple myeloma is important for the cancer's overall prognosis ...
Lower regulatory T cells (Tregs) at diagnosis in patients with multiple myeloma were linked to early relapse and may indicate functional high-risk status (FHR). FHR patients experience aggressive ...
The trial enrolled patients with unresectable metastatic melanoma who had at least 1 prior line of therapy that had to have the anti–PD-1 therapy backbone. They could or could not have had a BRAF ...
Of 924 patients included, 148 (16%) patients relapsed during a median follow-up of 6.3 years. Invasion of the testicular hilum (rete testis and hilar soft tissue), lymphovascular invasion, and ...
Tumor markers can help doctors diagnose testicular cancer, determine effective treatment, and monitor how well that treatment is working. Doctors have been using tumor markers to help diagnose and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback